Andere Sprachen Ovation Science Inc.

Aktien

A2N9GH

CA69016D1087

OVAT

Markt geschlossen - Canadian Securities Exchange Andere Börsenplätze 18:01:09 28.06.2024			% 5 Tage	% 1. Jan.
0.025 ^CAD	-.--%		-16.67%	-28.57%

29.05.	Ovation Science Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
07.05.	Ovation Science Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29.05.
Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07.05.
Ovation Science Topicals Launch with Planet 13 in Nevada	01.05.
Ovation Science Inc. Topicals Launch with Planet 13 Holdings Inc. in Nevada	30.04.
Ovation Science Expands Market Reach with Exclusive Canadian License Agreement	12.04.
Ovation Science Inc. Science Expands Market Reach with Exclusive Canadian License Agreement	11.04.
Ovation Science Inc. announced that it has received $0.05 million in funding	11.04.
Ovation Science Inc. announced that it expects to receive $0.05 million in funding	28.03.
Ovation Science Inc. announced that it expects to receive CAD 0.0675 million in funding	20.03.
Ovation Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28.11.
Ovation Science Inc. Signs License Agreement with Planet 13 Holdings, Inc	02.11.
Ovation Science Inc. Announces Executive Changes	30.10.23
Ovation Science Inc. Announces Board Changes	30.10.23
Ovation Science Inc. announced that it has received CAD 0.2 million in funding	12.10.23
Ovation Science : Announces Private Placement	04.10.23
Ovation Science Inc. announced that it expects to receive CAD 0.2 million in funding	03.10.23
Ovation Science Signs License Agreement with Planet 13 for Its Topical, Transdermal Cannabis Products for Nevada	12.09.23
Ovation Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29.08.23
Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	30.05.23
Ovation Science Inc. Signs Exclusive License Agreement for Its Topical Transdermal Cannabis Products for Pennsylvania	24.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ovation Science Inc.

Aktien

A2N9GH

CA69016D1087

OVAT

Andere Sprachen

Filter